Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) shares saw unusually-high trading volume on Thursday . 271,047 shares were traded during trading, an increase of 113% from the previous session’s volume of 127,418 shares.The stock last traded at $12.1967 and had previously closed at $11.72.
Analyst Ratings Changes
Separately, Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a research report on Tuesday, June 23rd. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, Fresenius SE & Co. presently has an average rating of “Buy”.
View Our Latest Analysis on FSNUY
Fresenius SE & Co. Price Performance
Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.01). Fresenius SE & Co. had a net margin of 6.55% and a return on equity of 10.09%. The business had revenue of $6.75 billion for the quarter, compared to analysts’ expectations of $6.79 billion. As a group, equities analysts expect that Fresenius SE & Co. will post 1.03 EPS for the current fiscal year.
Fresenius SE & Co. Company Profile
Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.
The company operates through four main business segments.
Featured Stories
- Five stocks we like better than Fresenius SE & Co.
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Receive News & Ratings for Fresenius SE & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. and related companies with MarketBeat.com's FREE daily email newsletter.
